[go: up one dir, main page]

MX343314B - Composiciones liquidas ionicas multifuncionales para superar el polimorfismo y proporcionar propiedades mejoradas a los ingredientes farmaceuticos, biologicos, nutricionales y energeticos activos. - Google Patents

Composiciones liquidas ionicas multifuncionales para superar el polimorfismo y proporcionar propiedades mejoradas a los ingredientes farmaceuticos, biologicos, nutricionales y energeticos activos.

Info

Publication number
MX343314B
MX343314B MX2012008021A MX2012008021A MX343314B MX 343314 B MX343314 B MX 343314B MX 2012008021 A MX2012008021 A MX 2012008021A MX 2012008021 A MX2012008021 A MX 2012008021A MX 343314 B MX343314 B MX 343314B
Authority
MX
Mexico
Prior art keywords
ionic liquid
liquid compositions
functional ionic
disclosed
methods
Prior art date
Application number
MX2012008021A
Other languages
English (en)
Inventor
T Daly Daniel
P Swatloski Richard
L Hough Whitney
Hillard Davis James
Smiglak Marcin
Pernak Juliusz
K Spear Scott
D Rogers Robin
Original Assignee
The Univ Of Alabama
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Univ Of Alabama filed Critical The Univ Of Alabama
Publication of MX343314B publication Critical patent/MX343314B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/58—1,2-Diazines; Hydrogenated 1,2-diazines
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N33/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic nitrogen compounds
    • A01N33/02—Amines; Quaternary ammonium compounds
    • A01N33/12—Quaternary ammonium compounds
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
    • A01N43/40—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/305—Mercury compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Agronomy & Crop Science (AREA)
  • Communicable Diseases (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

La presente invención se refiere a líquidos iónicos y métodos para preparar composiciones líquidas iónicas de ingredientes farmacéuticos, biológicos, nutricionales y energéticos activos. También se divulgan métodos para usar las composiciones descritas en el presente documento para superar el polimorfismo, superar la solubilidad y los problemas de entrega, para controlar las velocidades de liberación, añadir funcionalidad, mejorar la eficacia (sinergia) y mejorar la facilidad de uso y fabricación.
MX2012008021A 2005-10-07 2006-10-10 Composiciones liquidas ionicas multifuncionales para superar el polimorfismo y proporcionar propiedades mejoradas a los ingredientes farmaceuticos, biologicos, nutricionales y energeticos activos. MX343314B (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US72460405P 2005-10-07 2005-10-07
US72460505P 2005-10-07 2005-10-07
US76485006P 2006-02-02 2006-02-02
PCT/US2006/039454 WO2007044693A2 (en) 2005-10-07 2006-10-10 Multi-functional ionic liquid compositions

Publications (1)

Publication Number Publication Date
MX343314B true MX343314B (es) 2016-11-01

Family

ID=37943465

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012008021A MX343314B (es) 2005-10-07 2006-10-10 Composiciones liquidas ionicas multifuncionales para superar el polimorfismo y proporcionar propiedades mejoradas a los ingredientes farmaceuticos, biologicos, nutricionales y energeticos activos.

Country Status (11)

Country Link
US (2) US8232265B2 (es)
EP (1) EP1931760A4 (es)
JP (3) JP5713534B2 (es)
KR (2) KR20080068679A (es)
CN (2) CN101326275B (es)
AU (2) AU2006302237C1 (es)
BR (1) BRPI0616976A2 (es)
CA (2) CA2625004C (es)
IL (1) IL190646A (es)
MX (1) MX343314B (es)
WO (1) WO2007044693A2 (es)

Families Citing this family (133)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2558642C (en) 2004-03-10 2017-08-08 Monsanto Technology Llc Herbicidal compositions containing n-phosphonomethyl glycine and an auxin herbicide
MXPA06014303A (es) * 2004-06-07 2007-02-19 Syngenta Participations Ag Metodos para reducir el dano producido por nematodos.
MX343314B (es) 2005-10-07 2016-11-01 The Univ Of Alabama Composiciones liquidas ionicas multifuncionales para superar el polimorfismo y proporcionar propiedades mejoradas a los ingredientes farmaceuticos, biologicos, nutricionales y energeticos activos.
WO2007136873A2 (en) * 2006-05-19 2007-11-29 The Procter & Gamble Company Process for decarboxylation of fatty acids and oils to produce paraffins or olefins
WO2008093686A1 (ja) * 2007-01-29 2008-08-07 Medrx Co., Ltd. 非ステロイド系抗炎症薬と有機アミン化合物との塩とその用途
US9834516B2 (en) * 2007-02-14 2017-12-05 Eastman Chemical Company Regioselectively substituted cellulose esters produced in a carboxylated ionic liquid process and products produced therefrom
US10174129B2 (en) 2007-02-14 2019-01-08 Eastman Chemical Company Regioselectively substituted cellulose esters produced in a carboxylated ionic liquid process and products produced therefrom
US7919631B2 (en) * 2007-02-14 2011-04-05 Eastman Chemical Company Production of ionic liquids
MX2009008934A (es) * 2007-02-26 2009-08-28 Dow Agrosciences Llc Proceso para la preparacion de algunas sulfiliminas sustituidas.
WO2008115765A1 (en) * 2007-03-16 2008-09-25 Pathogen Systems, Inc. Method for aligning liquid crystals
CA2690773C (en) * 2007-07-10 2013-09-17 Medy-Tox, Inc. Pharmaceutical liquid composition of botulinum toxin with improved stability
EP2018864A1 (en) 2007-07-23 2009-01-28 Biomet Deutschland GmbH Pharmaceutical composition, substrate comprising a pharmaceutical composition, and use of a pharmaceutical composition
US8067632B2 (en) * 2007-07-26 2011-11-29 The Board Of Trustees Of The Leland Stanford Junior University Process to produce prostratin and structural or functional analogs thereof
EP2033945A1 (en) * 2007-09-06 2009-03-11 Infineum International Limited Quaternary ammonium salts
KR101072896B1 (ko) * 2007-10-09 2011-10-17 한미홀딩스 주식회사 이온성 액체 매개체를 이용한 몬테루카스트산의 제조 방법
DE102007053664A1 (de) * 2007-11-08 2009-05-14 Friedrich-Schiller-Universität Jena Optische Sensoren zur Detektion von Ionen, Gasen und Biomolekülen sowie Verfahren zu deren Herstellung und Verwendung
AR071339A1 (es) * 2008-02-05 2010-06-16 Arysta Lifescience North Ameri Formulacion solida de compuesto activo de baja fusion
US8188267B2 (en) 2008-02-13 2012-05-29 Eastman Chemical Company Treatment of cellulose esters
US9777074B2 (en) 2008-02-13 2017-10-03 Eastman Chemical Company Regioselectively substituted cellulose esters produced in a halogenated ionic liquid process and products produced therefrom
US8158777B2 (en) * 2008-02-13 2012-04-17 Eastman Chemical Company Cellulose esters and their production in halogenated ionic liquids
US8354525B2 (en) * 2008-02-13 2013-01-15 Eastman Chemical Company Regioselectively substituted cellulose esters produced in a halogenated ionic liquid process and products produced therefrom
CN104872125B (zh) 2008-07-03 2018-02-02 孟山都技术公司 作为除草剂辅助剂的衍生化糖表面活性剂和醚胺氧化物表面活性剂的组合
CA2638240C (en) * 2008-08-29 2010-02-02 Alexander Macgregor Method of treating dysglycemia and glucose excursions
US9278134B2 (en) * 2008-12-29 2016-03-08 The Board Of Trustees Of The University Of Alabama Dual functioning ionic liquids and salts thereof
WO2010078258A1 (en) * 2008-12-29 2010-07-08 The Board Of Trustees Of The University Of Alabama Compounds comprising two or more biologically functional ions and method of treating parkinson's disease
US8067488B2 (en) 2009-04-15 2011-11-29 Eastman Chemical Company Cellulose solutions comprising tetraalkylammonium alkylphosphate and products produced therefrom
WO2010141470A2 (en) 2009-06-01 2010-12-09 The Board Of Trustees Of The University Of Alabama Process for forming films, fibers, and beads from chitinous biomass
MX2012000535A (es) 2009-07-10 2012-03-29 Linzy O Scott Iii Métodos y composiciones para tratar afecciones médicas relacionadas con la tiroides con folatos reducidos.
WO2011019652A2 (en) 2009-08-10 2011-02-17 Monsanto Technology Llc Low volatility auxin herbicide formulations
CN101627767B (zh) * 2009-08-18 2013-03-20 深圳诺普信农化股份有限公司 一种含有虱螨脲的水乳剂及其制备方法
US9951008B2 (en) * 2009-11-03 2018-04-24 University Of Notre Dame Du Lac Ionic liquids comprising heteraromatic anions
US9289381B2 (en) 2009-12-03 2016-03-22 The University Of North Carolina At Charlotte Stabilization and storage of biological pharmaceutical compositions
EP2544664A1 (en) 2010-03-11 2013-01-16 Danmarks Tekniske Universitet Supported biologically active compounds
CN101851267A (zh) * 2010-04-22 2010-10-06 江南大学 一种抗体保护剂及其应用
US20130109572A1 (en) * 2010-07-06 2013-05-02 The Board Of Trustees Of The University Of Alabama Herbicidal compositions and methods of use
WO2012021825A2 (en) * 2010-08-12 2012-02-16 The Board Of Trustees Of The University Of Alabama Fungicidal compositions and methods of use
KR101319420B1 (ko) * 2011-03-18 2013-10-17 한남대학교 산학협력단 서방형 방출이 가능한 수용성 양이온 약물 전달 시스템
US9394375B2 (en) 2011-03-25 2016-07-19 Board Of Trustees Of The University Of Alabama Compositions containing recyclable ionic liquids for use in biomass processing
WO2012135178A1 (en) 2011-03-28 2012-10-04 The Board Of Trustees Of The University Of Alabama N-functionalized imidazole-containing systems and methods of use
US9096691B2 (en) 2011-04-13 2015-08-04 Eastman Chemical Company Cellulose ester optical films
WO2013005226A1 (en) 2011-07-04 2013-01-10 Zota Health Care Ltd A novel combined pharmaceutical composition containing diclofenac and methods of making and using the same
US20140309419A1 (en) 2011-08-31 2014-10-16 Danmarks Tekniske Universite Method for enhancing the thermal stability of ionic compounds
BR122019001044B1 (pt) 2011-10-26 2019-08-27 Monsanto Technology Llc sais herbicidas de auxina, mistura de aplicação herbicida compreendendo os mesmos para uso na eliminação e controle do crescimento de plantas indesejadas, bem como métodos de controle de plantas indesejadas e de plantas suscetíveis ao herbicida de auxina
WO2013082230A1 (en) * 2011-12-02 2013-06-06 The Board Of Trustees Of The University Of Alabama Imido-acid salts and methods of use
US20150038719A1 (en) * 2012-03-14 2015-02-05 Ltt Bio-Pharma Co., Ltd. Agent for Ameliorating Chronic Obstructive Pulmonary Disease
US20130252818A1 (en) * 2012-03-23 2013-09-26 Los Alamos National Security, Llc Amorphous bioinorganic ionic liquid compositions comprising agricultural substances
US8999292B2 (en) 2012-05-01 2015-04-07 Translatum Medicus Inc. Methods for treating and diagnosing blinding eye diseases
CN102697779B (zh) * 2012-06-01 2014-11-05 康阳润和（北京）医药科技有限公司 高溶散速率的伊来西胺药物组合物及其制法
UY34845A (es) 2012-06-04 2014-01-31 Monsanto Technology Llc ?composiciones herbicidas concentradas acuosas que contienen sales de glifosato y sales de dicamba
RU2015120080A (ru) 2012-11-05 2016-12-27 Монсанто Текнолоджи Ллс Смеси гербицидов на основе ауксина
US20140155625A1 (en) * 2012-11-30 2014-06-05 Xerox Corporation Modified Naturally-Derived Colorants For Phase Change Ink Applications
EP2961276B1 (en) 2013-02-27 2018-08-08 Monsanto Technology LLC Glyphosate and dicamba tank mixtures with improved volatility
US9126881B2 (en) 2013-06-28 2015-09-08 Uop Llc Catalytic isomerization of pentane using ionic liquids
US20150005554A1 (en) 2013-06-28 2015-01-01 Uop Llc Catalytic isomerization of butane using ionic liquids
US9102578B2 (en) 2013-06-28 2015-08-11 Uop Llc Catalytic isomerization of paraffins using ionic liquids
US9096483B2 (en) 2013-06-28 2015-08-04 Uop Llc Catalytic isomerization of hexanes using ionic liquids
US9096485B2 (en) 2013-06-28 2015-08-04 Uop Llc Catalytic isomerization of heptane using ionic liquids
US9096480B2 (en) 2013-06-28 2015-08-04 Uop Llc Catalytic disproportionation of heptane using ionic liquids
US9102577B2 (en) 2013-06-28 2015-08-11 Uop Llc Catalytic disproportionation of paraffins using ionic liquids
US9096481B2 (en) 2013-06-28 2015-08-04 Uop Llc Catalytic disproportionation of pentane using ionic liquids
US9096482B2 (en) 2013-06-28 2015-08-04 Uop Llc Catalytic reverse disproportionation of paraffins using ionic liquids
GB201313423D0 (en) * 2013-07-26 2013-09-11 Innospec Ltd Compositions and methods
US20160151503A1 (en) * 2013-08-01 2016-06-02 Mw Encap Limited Compositions and preparation methods of low melting ionic salts of poorly-water soluble drugs
CN103417546B (zh) * 2013-08-19 2016-01-27 中国人民解放军军事医学科学院基础医学研究所 亚甲蓝的一种麻醉后促清醒的用途
IL312865B1 (en) * 2013-09-11 2025-02-01 Eagle Biologics Inc Liquid protein formulations containing viscosity-reducing agents
US20150080468A1 (en) * 2013-09-13 2015-03-19 Quality Liquid Feeds Composition and method for processing and delivering bioavailable methionine analogs, derivatives, and precursors, thereof
CN103529146A (zh) * 2013-10-10 2014-01-22 中国热带农业科学院分析测试中心 采用离子液体提取鸡肉中磺胺类药物残留的方法
WO2015054887A1 (zh) * 2013-10-18 2015-04-23 浙江省诸暨合力化学对外贸易有限公司 三酮类铵盐化合物及其制备方法及应用
CN103626588B (zh) * 2013-12-03 2016-07-06 广西新方向化学工业有限公司 一种糖醇脲有机叶面肥
US9765196B2 (en) 2014-02-20 2017-09-19 Rutgers, The State University Of New Jersey Inorganic ionomers made from minerals
US9958363B2 (en) * 2014-06-23 2018-05-01 Agilent Technologies, Inc. Fluorous affinity extraction for ionic liquid-based sample preparation
GB201413355D0 (en) * 2014-07-28 2014-09-10 Innospec Ltd Compositons and methods
US10100131B2 (en) 2014-08-27 2018-10-16 The Board Of Trustees Of The University Of Alabama Chemical pulping of chitinous biomass for chitin
CN106715407A (zh) * 2014-09-25 2017-05-24 宝洁公司 离子液体
MX2017004306A (es) 2014-10-01 2017-12-20 Eagle Biologics Inc Formulaciones de polisacáridos y ácido nucleico que contienen agentes de reducción de viscosidad.
US10011931B2 (en) 2014-10-06 2018-07-03 Natural Fiber Welding, Inc. Methods, processes, and apparatuses for producing dyed and welded substrates
US10982381B2 (en) 2014-10-06 2021-04-20 Natural Fiber Welding, Inc. Methods, processes, and apparatuses for producing welded substrates
US10039758B2 (en) 2014-10-24 2018-08-07 Keck Graduate Institute Of Applied Life Sciences Compositions and methods for inhibiting bacterial and viral pathogens
CN104523588A (zh) * 2015-01-22 2015-04-22 华东理工常熟研究院有限公司 氨氯地平-硬脂酸离子液体及其制备方法和用途
US10722527B2 (en) 2015-04-10 2020-07-28 Capsugel Belgium Nv Abiraterone acetate lipid formulations
CN104860940B (zh) * 2015-05-22 2017-05-10 湖南省中医药研究院中药研究所 丙戊酸原小檗碱类化合物、制备方法和用途
US9393243B1 (en) * 2015-07-14 2016-07-19 Nilesh Parikh Topical Ciprofloxacin compositions
JP6546031B2 (ja) * 2015-08-06 2019-07-17 デクセリアルズ株式会社 イオン液体、潤滑剤及び磁気記録媒体
CN105388243B (zh) * 2015-12-09 2017-01-11 中国检验检疫科学研究院 一种化妆品中己脒定和氯己定及其盐类的测定方法
CN105623307B (zh) * 2015-12-21 2017-08-08 无锡科莱欣机电制造有限公司 蓝色环保型纺织染料混合物
US10357762B2 (en) 2016-01-26 2019-07-23 The Board Of Trustees Of The University Of Alabama Mixed metal double salt ionic liquids with tunable acidity
KR102591968B1 (ko) 2016-03-25 2023-10-20 네추럴 파이버 웰딩 인코포레이티드 용접된 기재를 제조하기 위한 방법, 공정, 및 장치
AU2017259983B2 (en) 2016-05-03 2021-08-19 Natural Fiber Welding, Inc. Methods, processes, and apparatuses for producing dyed and welded substrates
CN106265697A (zh) * 2016-08-16 2017-01-04 武汉软件工程职业学院 水杨酸混合物及其制备方法、水杨酸离子液体溶液及离子液体的用途
JP6816431B2 (ja) * 2016-09-29 2021-01-20 東レ株式会社 イオン塩、それを含有する熱可塑性樹脂組成物およびその製造方法
US10927191B2 (en) 2017-01-06 2021-02-23 The Board Of Trustees Of The University Of Alabama Coagulation of chitin from ionic liquid solutions using kosmotropic salts
WO2018155706A1 (ja) * 2017-02-27 2018-08-30 株式会社シード探索研究所 抗真菌組成物
WO2018236445A2 (en) 2017-03-24 2018-12-27 The Board Of Trustees Of The University Of Alabama METALLIC-CHITIN PARTICLE COMPOSITE MATERIALS AND METHODS OF MAKING SAME
WO2018222924A1 (en) * 2017-06-01 2018-12-06 Arizona Board Of Regents On Behalf Of Northern Arizona University Antibiofilm formulations
DE102017115701B4 (de) * 2017-07-12 2022-03-03 Lts Lohmann Therapie-Systeme Ag Fampridin-TTS
CN107501327B (zh) * 2017-07-20 2019-07-05 暨明医药科技（苏州）有限公司 环磷酰胺—水物的结晶方法
GB2566516A (en) 2017-09-15 2019-03-20 Univ Oxford Innovation Ltd Electrochemical recognition and quantification of cytochrome c oxidase expression in bacteria
EP3709974A4 (en) * 2017-11-17 2021-08-04 President And Fellows Of Harvard College IONIC LIQUIDS FOR INTERNAL ADMINISTRATION
WO2019126739A1 (en) 2017-12-21 2019-06-27 Shepherd Therapeutics, Inc. Pyrvinium pamoate anti-cancer therapies
CN109173956B (zh) * 2018-03-01 2020-05-26 中国石油大学(北京) 处理氯铝酸类离子液体废催化剂和碱性废水的系统
CN110386869A (zh) * 2018-04-20 2019-10-29 华东理工大学 布洛芬离子液体及其制备方法
CN110496115B (zh) * 2018-05-18 2022-10-25 华东理工大学 二甲双胍离子液体及其制备和应用
EP3593637B1 (en) * 2018-07-11 2023-09-06 Fine Agrochemicals Limited Plant growth regulator concentrate and use thereof
US11643438B2 (en) 2018-07-20 2023-05-09 The Board Of Regents Of The University Of Oklahoma Antimicrobial peptides and methods of use
WO2020028684A1 (en) * 2018-08-01 2020-02-06 Jumpstart Fertility Pty Ltd Salts of nicotinic acid and nicotinamide as anti-aging agents
CN109187948B (zh) * 2018-08-17 2021-10-29 郑州大学 一种洛克沙胂和硝苯胂酸双联检测试纸
CN109211862B (zh) * 2018-10-23 2021-03-30 山西大学 一种红色荧光铜纳米团簇探针的制备方法及其应用
RU2749902C2 (ru) * 2018-10-31 2021-06-18 Общество С Ограниченной Ответственностью "Валента-Интеллект" Фармацевтическая композиция для лечения инфекционно-воспалительных заболеваний
CN111825742B (zh) * 2019-04-18 2024-01-30 陈铭 Ctpa作为特种偶合剂用于氨基酸离子液体的多肽固相合成
CN110064396B (zh) * 2019-04-25 2020-05-01 山东大学 基于还原性离子液体的富含氧空位的三氧化二铁固氮催化剂、制备方法及其电催化固氮应用
EP3990433A4 (en) 2019-06-25 2023-07-26 Translatum Medicus Inc. METHODS FOR THE MANUFACTURE OF 2-((1-BENZYL-1H-INDAZOL-3-YL)METHOXY)-2-METHYLPROPANOIC ACID AND ITS DERIVATIVES
CN110881481B (zh) * 2019-10-30 2021-04-06 广州市浪奇实业股份有限公司 一种含有大麻叶提取物的抗菌组合物及其应用
CN112755196B (zh) * 2019-11-01 2024-02-27 华东理工大学 多奈哌齐离子液体
CN110894207B (zh) * 2019-11-21 2023-03-31 宁夏泰益欣生物科技股份有限公司 一种盐酸克林霉素棕榈酸酯的纯化方法
CN112909328A (zh) * 2019-12-04 2021-06-04 中国科学院宁波材料技术与工程研究所 一种超薄硫化物固体电解质层及其制备方法和应用
KR102102402B1 (ko) * 2019-12-05 2020-04-20 유은옥 고형 화장비누 제조방법
CN111272717B (zh) * 2020-02-10 2024-02-27 河南师范大学 基于离子液体新型荧光碳点的一步水热合成及其对磺胺噻唑的检测应用
CN111302930B (zh) * 2020-03-12 2023-11-07 湖南复瑞生物医药技术有限责任公司 一种对苯丁氧基苯甲酸的制备方法
CN111253289A (zh) * 2020-03-27 2020-06-09 湖南吴赣药业有限公司 一种磺胺醋酰钠的合成方法
US11116737B1 (en) 2020-04-10 2021-09-14 University Of Georgia Research Foundation, Inc. Methods of using probenecid for treatment of coronavirus infections
JP2023528843A (ja) * 2020-06-04 2023-07-06 シンジェンタ クロップ プロテクション アクチェンゲゼルシャフト 殺菌性組成物
AR122189A1 (es) * 2020-06-04 2022-08-24 Syngenta Crop Protection Ag Composiciones fungicidas
AR122484A1 (es) * 2020-06-04 2022-09-14 Syngenta Crop Protection Ag Composiciones fungicidas
CN112089823B (zh) * 2020-09-25 2024-02-06 珠海中科先进技术研究院有限公司 一种短梗霉素a和制霉菌素组合物及其复合软膏、凝胶剂以及喷剂
BR102020026974A2 (pt) * 2020-12-29 2022-07-12 Universidade Estadual De Campinas - Unicamp Processo de obtenção de composições nutracêuticas e composições nutracêuticas assim obtidas
CN112674106B (zh) * 2021-01-06 2021-12-07 沈阳农业大学 一种可溶液剂及其制备方法
US12005134B2 (en) 2021-06-30 2024-06-11 Abe Pharmaceutical Composition for stimulating facial hair growth and methods of manufacturing a composition for stimulating facial hair growth
CN113788788B (zh) * 2021-07-23 2023-12-05 浙江工业大学 一种荧光离子液体及其合成方法与应用
CN114539336B (zh) * 2022-01-24 2023-06-30 河北圣雪大成制药有限责任公司 一种阿维拉霉素a的提纯方法
CN114642733B (zh) * 2022-03-02 2023-08-22 中山大学 一种治疗雄激素源性脱发的组合物及其制备方法
CN116407557A (zh) * 2023-05-29 2023-07-11 四川大学华西医院 一种防治出血性脑卒中的药物组合物及其应用
CN116622514B (zh) * 2023-07-21 2023-10-20 南京师范大学 提高微生物菌体和/或微生物油脂中多不饱和脂肪酸含量的调控方法及应用
CN117643551B (zh) * 2024-01-30 2024-03-29 广州悦瑞化妆品有限公司 一种多肽次抛精华及其制备方法

Family Cites Families (96)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1943176A (en) * 1930-09-27 1934-01-09 Chem Ind Basel Cellulose solution
US2004891A (en) * 1931-12-08 1935-06-11 Novocol Chemical Mfg Co Inc Anaesthetic composition
GB869149A (en) 1958-09-16 1961-05-31 Clinical Products Ltd Liquid pharmaceutical compositions comprising compounds of ion exchange resins and therapeutic substances
US3223704A (en) * 1961-10-27 1965-12-14 Hollichem Corp Quaternary ammonium sulfamates
US3344018A (en) * 1961-10-27 1967-09-26 Hollichem Corp Biocidal quaternary ammonium sulfamates
NL302478A (es) 1962-12-24
DE1443879C3 (de) * 1964-02-21 1974-07-25 Bayer Ag, 5090 Leverkusen Ungesättigte quartäre Ammoniumverbindungen und Verfahren zu deren Herstellung
GB1067094A (en) 1964-05-12 1967-05-03 Hollichem Corp Quaternary ammonium sulfamates
FR1404697A (fr) 1964-06-09 1965-07-02 Hollichem Corp Nouveaux sulfamates d'ammonium quaternaire
US3471423A (en) * 1966-11-07 1969-10-07 Gen Tire & Rubber Co Polyurethane materials having biocidal properties and their production
US4104368A (en) * 1970-05-11 1978-08-01 Millmaster Onyx Corporation Composition and method for protecting skin and hair
US4001394A (en) 1974-01-30 1977-01-04 American Cyanamid Company Shampoo creme rinse containing a quaternary ammonium saccharinate, cyclamate or phthalimidate
US4097666A (en) 1976-04-29 1978-06-27 The Institute Of Paper Chemistry Solvent system for polysaccharides
DE2703703A1 (de) * 1977-01-29 1978-08-03 Dynamit Nobel Ag Traegergebundene acylasen
DE2737118A1 (de) 1977-08-17 1979-03-01 Projektierung Chem Verfahrenst Verfahren zur gewinnung von zuckern, gegebenenfalls cellulose und gegebenenfalls lignin aus lignocellulosischen pflanzlichen rohstoffen
US4171352A (en) * 1977-08-22 1979-10-16 Polysciences, Inc. Quantitative evaluation of enteric microbial overgrowth
US4228162A (en) * 1979-07-09 1980-10-14 Research Corporation Dimethyl isosorbide in liquid formulation of aspirin
US4224319A (en) * 1979-07-31 1980-09-23 Ernest Marcadet Antiseptic composition for topical application to the skin
DE3267656D1 (en) 1981-04-24 1986-01-09 Ciba Geigy Ag Herbicidal agents
US4421547A (en) * 1982-04-06 1983-12-20 Stauffer Chemical Company 4-Hydroxy-5-isopropyl-2-methylphenyl trimethylammonium, 1-piperidine carboxylate salt of N-phosphonomethylglycine and its use as a herbicide
US4491574A (en) * 1983-03-02 1985-01-01 Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University Reduction of high dose aspirin toxicity by dietary vitamin A
ES521561A0 (es) 1983-04-18 1984-08-01 Lacer Sa Procedimiento para la obtencion de amonios cuaternarios insolubles
CA1242748A (en) 1984-11-26 1988-10-04 Rita S. Jones Salt of dicamba
US4761164A (en) * 1985-03-01 1988-08-02 Air Products And Chemicals, Inc. Method for gas separation
JPS61236818A (ja) 1985-04-15 1986-10-22 Masako Matsumoto エポキシ樹脂硬化剤
JPS62198609A (ja) 1986-02-26 1987-09-02 Toray Ind Inc 化粧品又は医薬部外品配合用粒子
JPS6356501A (ja) 1986-08-26 1988-03-11 Chisso Corp アフイニテイークロマトグラフイー用カラム充填剤及びその製造方法
NZ226377A (en) 1988-09-28 1992-06-25 Nigel Paul Maynard Water-insoluble biocidal or preservative composition comprising a borate organic complex ion and a biocidally active cationic species
US4973456A (en) * 1988-10-24 1990-11-27 Air Products And Chemicals, Inc. Use of salt hydrates as reversible absorbents of acid gases
NZ231897A (en) * 1988-12-30 1992-09-25 Monsanto Co Dry water-soluble granular composition comprising glyphosate and a liquid surfactant
DE69119752T2 (de) 1990-03-06 1997-01-23 Tate Fungizide zusammensetzungen zur anwendung bei pflanzen
US5275820A (en) * 1990-12-27 1994-01-04 Allergan, Inc. Stable suspension formulations of bioerodible polymer matrix microparticles incorporating drug loaded ion exchange resin particles
FR2735658B1 (fr) * 1995-06-21 1997-09-12 Capsulis Encapsulation de composes a usage alimentaire par des tensioactifs
US5246716A (en) 1992-01-10 1993-09-21 W. Neudorff Gmbh Kg Fatty acid-based antifungal composition having residual activity
US5428000A (en) 1992-06-26 1995-06-27 Toho Chemical Industry Co., Ltd. Antagonism inhibitors for herbicides, herbicide compositions and herbicidal methods
DE4308410A1 (de) 1993-03-12 1994-09-15 Schering Ag Verfahren zur Synthese und Selektionierung von Sequenzen aus kovalent verbundenen Bausteinen
AT399519B (de) * 1993-09-14 1995-05-26 Chemiefaser Lenzing Ag Form- bzw. spinnmasse enthaltend cellulose und verfahren zur herstellung cellulosischer formkörper
GB9402569D0 (en) 1994-02-10 1994-04-06 Bp Chem Int Ltd Alkylation process
GB9402612D0 (en) 1994-02-10 1994-04-06 British Petroleum Co Plc Ionic liquids
AU1584895A (en) 1994-02-10 1995-08-29 Bp Chemicals Limited Ionic liquids
WO1996006593A1 (en) 1994-08-31 1996-03-07 J.M. Huber Corporation Cost effective dental compositions containing novel sodium aluminosilicates
KR970707328A (ko) * 1994-11-03 1997-12-01 뷰거 홀스트 재생 셀룰로오즈의 형성 형상 및 그 제조 방법
ES2244958T3 (es) * 1994-12-21 2005-12-16 Hydro Quebec Sales hidrofobicas liquidas, su prepracion y su aplicacion en electroquimica.
US5654337A (en) * 1995-03-24 1997-08-05 II William Scott Snyder Topical formulation for local delivery of a pharmaceutically active agent
US5827602A (en) * 1995-06-30 1998-10-27 Covalent Associates Incorporated Hydrophobic ionic liquids
CA2176515C (en) 1996-05-14 1996-10-22 Eckhard H. Biller Fire suppressant foam, dispersant and detergent eckhard iii - formula
JP3019776B2 (ja) 1996-07-04 2000-03-13 三菱化学株式会社 Ｎ−アルキル−ｎ′−メチルイミダゾリニウム有機酸塩の製造方法
US5731101A (en) * 1996-07-22 1998-03-24 Akzo Nobel Nv Low temperature ionic liquids
AU734429B2 (en) * 1997-05-14 2001-06-14 Galen (Chemicals) Limited Topical compositions
US20020010291A1 (en) * 1998-12-04 2002-01-24 Vince Murphy Ionic liquids and processes for production of high molecular weight polyisoolefins
DE19919494A1 (de) * 1999-04-29 2000-11-02 Celanese Chem Europe Gmbh Ionische Flüssigkeiten, ihre Herstellung und ihre Verwendung
GB9919558D0 (en) * 1999-08-18 1999-10-20 Hoechst Schering Agrevo Gmbh Fungicidal compounds
GB9928290D0 (en) * 1999-12-01 2000-01-26 Univ Belfast Process for preparing ambient temperature ionic liquids
GB0008707D0 (en) * 2000-04-07 2000-05-31 Bp Chem Int Ltd Imidazole carbenes
DE10022987A1 (de) * 2000-05-11 2001-11-22 Aventis Cropscience Gmbh Kombinationen von Pflanzenschutzmitteln mit kationischen Polymeren
ATE266008T1 (de) * 2000-10-27 2004-05-15 Centre Nat Rech Scient Imidazolium-salze und die verwendung dieser ionischen flüssigkeiten als lösungsmittel und als katalysator
DE10063960A1 (de) 2000-12-20 2002-06-27 Aventis Cropscience Gmbh Herbizide Mittel
WO2002079269A1 (en) * 2001-03-30 2002-10-10 Uab Research Foundation Polymer formation in room temperature ionic liquids
GB2374082A (en) * 2001-04-04 2002-10-09 Procter & Gamble Particles for a detergent product
US6846926B1 (en) * 2001-06-06 2005-01-25 The United States Of America As Represented By The Secretary Of The Navy Triazolyl-aminotriazine compositions, including salts
DE10130298A1 (de) * 2001-06-22 2003-01-23 Nutrinova Gmbh Antimikrobiell wirksame Acesulfam-Komplexe, Verfahren zu ihrer Herstellung und ihre Verwendung
WO2003032729A1 (en) * 2001-09-26 2003-04-24 Platte Chemical Co. Herbicide compositions comprising imidazolinone acid
US6824599B2 (en) * 2001-10-03 2004-11-30 The University Of Alabama Dissolution and processing of cellulose using ionic liquids
US6808557B2 (en) * 2001-10-03 2004-10-26 The University Of Alabama Cellulose matrix encapsulation and method
JP2005517024A (ja) * 2002-02-07 2005-06-09 イッサム リサーチ ディベロプメント カンパニー オブ ザ ヘブリュー ユニバーシティ オブ エルサレム 生物学的障壁を横切る透過を促進し得るアミノ酸配列
US20040007693A1 (en) * 2002-07-03 2004-01-15 Roger Moulton Ionic liquids containing borate or phosphate anions
US7883715B2 (en) * 2002-08-31 2011-02-08 Monsanto Technology Llc Pesticide compositions containing dicarboxylic acids
US7166641B2 (en) * 2002-10-02 2007-01-23 Yung Shin Pharmaceutical Industrial Co., Ltd. Pharmaceutically acceptable salts containing local anesthetic and anti-inflammatory activities and methods for preparing the same
CN1235479C (zh) * 2002-11-28 2006-01-11 四川贝尔实业有限责任公司 草甘膦异丙胺盐水剂的制备方法
EP1599186B1 (en) 2003-02-24 2013-04-10 Pharmaceutical Productions Inc. Transmucosal drug delivery system
US7114146B2 (en) * 2003-05-02 2006-09-26 International Business Machines Corporation System and method of dynamic service composition for business process outsourcing
US7572409B2 (en) * 2003-05-23 2009-08-11 Applied Biosystems, Llc Ionic liquid apparatus and method for biological samples
JP4669960B2 (ja) * 2003-06-03 2011-04-13 株式会社 メドレックス 局所麻酔薬を含有する口中用または咽頭部用製剤
JP2005082512A (ja) 2003-09-05 2005-03-31 Medorekkusu:Kk イオン性の薬物の経皮吸収性を高めた外用剤
US20050058702A1 (en) * 2003-09-17 2005-03-17 Ben-Sasson Shmuel A. Compositions capable of facilitating penetration across a biological barrier
US20050136103A1 (en) * 2003-09-17 2005-06-23 Ben-Sasson Shmuel A. Compositions capable of facilitating penetration across a biological barrier
WO2005028446A1 (ja) 2003-09-18 2005-03-31 Sumitomo Chemical Company, Limited イオン性液体及びそれを使用する反応方法
WO2005037264A1 (ja) * 2003-10-17 2005-04-28 Medrx Co., Ltd. ビグアナイド系薬剤を含有するゼリー製剤
US20050127319A1 (en) 2003-12-10 2005-06-16 Sanyo Chemical Industries, Ltd. Electrolytic solution for an electrochemical capacitor and an electrochemical capacitor using the same
AU2005208902A1 (en) * 2004-01-26 2005-08-11 University Of South Alabama Anionic-sweetener-based ionic liquids and methods of use thereof
ES2372959T3 (es) * 2004-01-29 2012-01-30 Medrx Co., Ltd. Analgésico anti-inflamatorio para uso externo.
GB0407908D0 (en) * 2004-04-07 2004-05-12 Univ York Ionic liquids
NZ550320A (en) * 2004-04-15 2010-02-26 Chiasma Inc Compositions capable of facilitating penetration across a biological barrier
EP1903861B1 (en) 2005-06-29 2015-12-30 Syngenta Participations AG Liquid compositions for treating plant propagation materials
JP4750499B2 (ja) * 2005-08-01 2011-08-17 日華化学株式会社 イオン性液体並びにそれを用いた抗菌剤及び抗菌性繊維
MX343314B (es) 2005-10-07 2016-11-01 The Univ Of Alabama Composiciones liquidas ionicas multifuncionales para superar el polimorfismo y proporcionar propiedades mejoradas a los ingredientes farmaceuticos, biologicos, nutricionales y energeticos activos.
US20090264664A1 (en) * 2005-10-21 2009-10-22 Medrx Co., Ltd. Preparation for external application comprising salt of mast cell degranulation inhibitor having carboxyl group with organic amine
WO2008093686A1 (ja) * 2007-01-29 2008-08-07 Medrx Co., Ltd. 非ステロイド系抗炎症薬と有機アミン化合物との塩とその用途
CN101594905A (zh) * 2007-01-29 2009-12-02 株式会社医药处方 生产热敏物质微针的方法
WO2008098032A2 (en) 2007-02-06 2008-08-14 North Carolina State University Use of lignocellulosics solvated in ionic liquids for production of biofuels
EP2124561A2 (en) * 2007-02-26 2009-12-02 Dow AgroSciences LLC Ionic liquids derived from herbicidal carboxylic acids and certain trialkylamines or heteroarylamines
US8722065B2 (en) 2007-11-11 2014-05-13 Medrx Co., Ltd. Lidocaine tape preparation
KR101514342B1 (ko) 2007-11-22 2015-04-22 가부시키가이샤 메드렉스 지방산계 이온 액체를 유효성분으로 하는 외용제 조성물
US8697096B2 (en) * 2007-12-11 2014-04-15 Medrx Co., Ltd. Tape preparation comprising etodolac in ionic liquid form
CA2619367A1 (en) 2008-01-29 2009-07-29 Medrx Co., Ltd. Gel preparation for oral administration
EP2266626B1 (en) 2008-03-28 2014-06-18 AnGesMG, Inc. Composition for external application comprising transcription factor decoy as active ingredient

Also Published As

Publication number Publication date
US8232265B2 (en) 2012-07-31
BRPI0616976A2 (pt) 2009-11-24
CN101326275B (zh) 2013-06-05
JP5713534B2 (ja) 2015-05-07
AU2012203353A1 (en) 2012-06-28
CN101326275A (zh) 2008-12-17
AU2006302237B2 (en) 2012-03-08
KR20130114214A (ko) 2013-10-16
AU2012203353B9 (en) 2014-10-23
AU2006302237C1 (en) 2012-11-08
CN103271083B (zh) 2017-08-11
US8802596B2 (en) 2014-08-12
JP2009511497A (ja) 2009-03-19
CA2625004A1 (en) 2007-04-19
WO2007044693A3 (en) 2007-08-23
EP1931760A2 (en) 2008-06-18
IL190646A0 (en) 2008-12-29
CA2625004C (en) 2015-10-06
IL190646A (en) 2013-06-27
AU2006302237A1 (en) 2007-04-19
JP2014205720A (ja) 2014-10-30
CN103271083A (zh) 2013-09-04
CA2867194A1 (en) 2007-04-19
US20070093462A1 (en) 2007-04-26
AU2012203353B2 (en) 2012-06-28
JP2012255022A (ja) 2012-12-27
KR20080068679A (ko) 2008-07-23
CA2867194C (en) 2016-10-04
US20120264605A1 (en) 2012-10-18
WO2007044693A2 (en) 2007-04-19
KR101592659B1 (ko) 2016-02-11
EP1931760A4 (en) 2010-10-20

Similar Documents

Publication Publication Date Title
MX343314B (es) Composiciones liquidas ionicas multifuncionales para superar el polimorfismo y proporcionar propiedades mejoradas a los ingredientes farmaceuticos, biologicos, nutricionales y energeticos activos.
MY143795A (en) Tetrahydropyridoindole derivatives
TW200744665A (en) Vitamin E succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof
ZA200809864B (en) Pharmaceutical formulations for the sustained release of active ingredients(s), as well as their applications, especially therapeutic
WO2007077561A3 (en) Compositions and methods for enhancing in-vivo uptake of pharmaceutical agents
TW200716202A (en) Pediatric formulation of topiramate
ATE470443T1 (de) Indol-1-yl-essigsäurederivate
TW200633716A (en) Compositions and methods for stabilizing active pharmaceutical ingredients
BRPI0707612B8 (pt) vaso lacrado e formulações líquidas contidas no mesmo
WO2007149406A8 (en) Modified coagulation factor ix polypeptides and use thereof for treatment
EA200801275A1 (ru) Стабилизированные составы карбоната лантана
PL1791532T3 (pl) Kompozycja w mikropeletkach o kontrolowanym uwalnianiu substancji fizjologicznie czynnych, sposób jej wytwarzania i jej zastosowanie w dziedzinie zootechniki
TW200621268A (en) Antimicrobial copolymers and uses thereof
WO2008087367A3 (fr) Derives de (phenylthiazolyl)-phenyl-propan-1-one et de (phenyloxazodyl)-phenyl-propan-1-one substitues, preparations et utilisations
WO2007025988A3 (en) Liquid formulations of pegylated growth hormone
WO2010021607A3 (en) Pharmaceutical formulation
EP2279732A3 (en) Compounds and compositions for delivering active agents
DE502005005636D1 (en) Spirocyclische cyclohexan-derivate
WO2011069037A3 (en) Stabilization and storage of biological pharmaceutical compositions
MY144897A (en) 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists
WO2007077318A3 (fr) Utilisation d'un extrait peptidique de riz en tant qu'agent actif inducteur de la synthese des proteines sirt dans les cellules de la peau
EA200701172A1 (ru) 2-алкокси-3,4,5-тригидроксиалкиламиды, их получение, композиции, их содержащие, и применение
NO20082848L (no) Farmasoytisk formulering for behandling av osteoartritt inneholdende klodronsyre og hyaluronsyre
GB0615105D0 (en) Novel compounds
TR200909785A1 (tr) Aktif ajan olarak sefdinir içeren farmasötik kompozisyonlar.